These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 21080338

  • 61. Inhibition of human ovarian cancer cell proliferation in vitro by ginsenoside Rh2 and adjuvant effects to cisplatin in vivo.
    Kikuchi Y, Sasa H, Kita T, Hirata J, Tode T, Nagata I.
    Anticancer Drugs; 1991 Feb; 2(1):63-7. PubMed ID: 1958854
    [Abstract] [Full Text] [Related]

  • 62. The anti-tumor effect of ginsenoside Rh4 in MCF-7 breast cancer cells in vitro and in vivo.
    Duan Z, Wei B, Deng J, Mi Y, Dong Y, Zhu C, Fu R, Qu L, Fan D.
    Biochem Biophys Res Commun; 2018 May 15; 499(3):482-487. PubMed ID: 29596831
    [Abstract] [Full Text] [Related]

  • 63. Research Progress on the Antitumor Molecular Mechanism of Ginsenoside Rh2.
    Yang L, Chen JJ, Sheng-Xian Teo B, Zhang J, Jiang M.
    Am J Chin Med; 2024 May 15; 52(1):217-230. PubMed ID: 38291582
    [Abstract] [Full Text] [Related]

  • 64. Inhibitory effects by oral administration of ginsenoside Rh2 on the growth of human ovarian cancer cells in nude mice.
    Tode T, Kikuchi Y, Kita T, Hirata J, Imaizumi E, Nagata I.
    J Cancer Res Clin Oncol; 1993 May 15; 120(1-2):24-6. PubMed ID: 8270603
    [Abstract] [Full Text] [Related]

  • 65. Ginsenoside Rh2 induces DNA damage and autophagy in vestibular schwannoma is dependent of LAMP2 transcriptional suppression.
    Yang D, Li X, Zhang X.
    Biochem Biophys Res Commun; 2020 Feb 05; 522(2):300-307. PubMed ID: 31771882
    [Abstract] [Full Text] [Related]

  • 66. Esterification of Ginsenoside Rh2 Enhanced Its Cellular Uptake and Antitumor Activity in Human HepG2 Cells.
    Chen F, Deng ZY, Zhang B, Xiong ZX, Zheng SL, Tan CL, Hu JN.
    J Agric Food Chem; 2016 Jan 13; 64(1):253-61. PubMed ID: 26672619
    [Abstract] [Full Text] [Related]

  • 67. Pseudo-Ginsenoside Rh2 induces A549 cells apoptosis via the Ras/Raf/ERK/p53 pathway.
    Wang Y, Xu H, Lu Z, Yu X, Lv C, Tian Y, Sui D.
    Exp Ther Med; 2018 Jun 13; 15(6):4916-4924. PubMed ID: 29805515
    [Abstract] [Full Text] [Related]

  • 68. Induction of apoptosis in prostate cancer by ginsenoside Rh2.
    Tong-Lin Wu T, Tong YC, Chen IH, Niu HS, Li Y, Cheng JT.
    Oncotarget; 2018 Feb 16; 9(13):11109-11118. PubMed ID: 29541400
    [Abstract] [Full Text] [Related]

  • 69. Anti-apoptotic proteins induce non-random genetic alterations that result in selecting breast cancer metastatic cells.
    Méndez O, Fernández Y, Peinado MA, Moreno V, Sierra A.
    Clin Exp Metastasis; 2005 Feb 16; 22(4):297-307. PubMed ID: 16170666
    [Abstract] [Full Text] [Related]

  • 70. Anticancer Effects of Ginsenoside Rh2: A Systematic Review.
    He XL, Xu XH, Shi JJ, Huang M, Wang Y, Chen X, Lu JJ.
    Curr Mol Pharmacol; 2022 Feb 16; 15(1):179-189. PubMed ID: 33687905
    [Abstract] [Full Text] [Related]

  • 71. AMP-activated protein kinase determines apoptotic sensitivity of cancer cells to ginsenoside-Rh2.
    Kim MJ, Yun H, Kim DH, Kang I, Choe W, Kim SS, Ha J.
    J Ginseng Res; 2014 Jan 16; 38(1):16-21. PubMed ID: 24558305
    [Abstract] [Full Text] [Related]

  • 72. Atranorin, an antimicrobial metabolite from lichen Parmotrema rampoddense exhibited in vitro anti-breast cancer activity through interaction with Akt activity.
    Harikrishnan A, Veena V, Lakshmi B, Shanmugavalli R, Theres S, Prashantha CN, Shah T, Oshin K, Togam R, Nandi S.
    J Biomol Struct Dyn; 2021 Mar 16; 39(4):1248-1258. PubMed ID: 32096436
    [Abstract] [Full Text] [Related]

  • 73. Ginsenoside Rg3 Induces Apoptosis of Human Breast Cancer (MDA-MB-231) Cells.
    Kim BM, Kim DH, Park JH, Na HK, Surh YJ.
    J Cancer Prev; 2013 Jun 16; 18(2):177-85. PubMed ID: 25337544
    [Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. Differential expression of protein kinase C subtypes during ginsenoside Rh2-lnduced apoptosis in SK-N-BE(2) and C6Bu-1 cells.
    Kim YS, Jin SH, Lee YH, Park JD, Kim SI.
    Arch Pharm Res; 2000 Oct 16; 23(5):518-24. PubMed ID: 11059834
    [Abstract] [Full Text] [Related]

  • 76. EGFR-Targeted Liposomes Combined with Ginsenoside Rh2 Inhibit Triple-Negative Breast Cancer Growth and Metastasis.
    Gu H, Shi R, Xu C, Lv W, Hu X, Xu C, Pan Y, He X, Wu A, Li J.
    Bioconjug Chem; 2023 Jun 21; 34(6):1157-1165. PubMed ID: 37235785
    [Abstract] [Full Text] [Related]

  • 77. The identification of molecular target of (20S) ginsenoside Rh2 for its anti-cancer activity.
    Wang YS, Lin Y, Li H, Li Y, Song Z, Jin YH.
    Sci Rep; 2017 Sep 29; 7(1):12408. PubMed ID: 28963461
    [Abstract] [Full Text] [Related]

  • 78. Ginsenoside Rh2 represses autophagy to promote cervical cancer cell apoptosis during starvation.
    Wang J, Bian S, Wang S, Yang S, Zhang W, Zhao D, Liu M, Bai X.
    Chin Med; 2020 Nov 12; 15(1):118. PubMed ID: 33292331
    [Abstract] [Full Text] [Related]

  • 79. [Synthesis and anti-tumor activity of ginsenoside Rh_2 caprylic acid monoester].
    Zhang WY, Liu FG, Zheng YN.
    Zhongguo Zhong Yao Za Zhi; 2019 Sep 12; 44(17):3758-3762. PubMed ID: 31602950
    [Abstract] [Full Text] [Related]

  • 80. Apoptosis and in vivo models to study the molecules related to this phenomenon.
    Luchs A, Pantaleão C.
    Einstein (Sao Paulo); 2010 Dec 12; 8(4):495-7. PubMed ID: 26760337
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.